Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Cell Lysis And Disruption Market Size, Share & Trends Analysis, 2023-2030" report has been added to ResearchAndMarkets.com's offering.
Global industry dynamics underline a surge in demand for biopharmaceutical development, steering the cell lysis and disruption market on a path of accelerating growth from 2023 to 2030. Technical advancements and increased adoption rates are driving forecasted revenues up to USD 9.63 billion, powered by an impressive CAGR of 8.7%. This granular research publication offers detailed insights into market trends, share, and size.
Key takeaways from the report illuminate that enzyme-based cell lysis techniques are expected to chart the fastest growth trajectory, benefiting from biological specificity that bolsters their utility in protein, DNA, and RNA extraction and purification. Simultaneously, the segment offering reagents and consumables, by virtue of their compatibility with various tissue types and laboratory requisites, is anticipated to register considerable growth.
Market Highlights
- Expanding biologics development underscores robust demand for efficient and specialized cell disruption methods.
- The application of enzymatic lysis techniques predicts a sharp growth rate across the market.
- Physical methods such as sonication exhibit significant revenue share, attributed to high product yield and precision control.
Additionally, the study spotlights the mammalian cell culture systems for their escalated prominence within biopharmaceutical production, marking an increase in demand for cell lysis solutions. Pharmaceuticals and biotechnology companies maintain a significant stance as the leading end-use segment, and research geared towards nucleic-acid derived products is set to propel industry progression.
In a geographical context, the Asia Pacific market is slated as the fastest-growing region—a result of lucrative opportunities and increased global investment. Key players are leveraging new product development and strategic partnerships to fortify their standing within this burgeoning market.
The latest market insights into the cell lysis and disruption field serve as a pivotal hub of knowledge for stakeholders, guiding economic strategies and policy decisions. The comprehensive report addresses a multitude of factors influencing market contours and is poised to be an essential resource for entities navigating this sector.
Core Applications and Advancements:
- Enhancements in biopharmaceutical processing fuel application growth.
- Innovative reagent solutions catering to specific tissue types.
- Increased interest in mammalian cell systems for cell lysis protocol demands.
- Substantial research investments in the nucleic-acid derived products space.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2022-2030 |
| Estimated Market Value (USD) in 2022 | $4.89 Billion |
| Forecasted Market Value (USD) by 2030 | $9.63 Billion |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | Global |
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd.
- QIAGEN
- Danaher
- Miltenyi Biotec
- Claremont BioSolutions, LLC
- IDEX
- Parr Instrument Company
- Covaris, LLC
- Cell Signaling Technology, Inc.
- Qsonica
- BD
For more information about this report visit https://www.researchandmarkets.com/r/70u318
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
